Comparison of the EQ-5D and SF-12 in an adult US sample

被引:254
|
作者
Johnson, JA
Coons, SJ
机构
[1] Univ Alberta, Inst Pharmacoecon, Edmonton, AB T5J 3S9, Canada
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
[3] Univ Arizona, Dept Pharm Practice & Sci, Tucson, AZ USA
关键词
EQ-5D; SF-12; validity; comparison;
D O I
10.1023/A:1008809610703
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this paper is to discuss the results of a direct comparison of two instruments, the SF-12 health survey and the EuroQol Group's EQ-5D, in a sample drawn from the adult US population. The data were collected via a survey instrument mailed to 1,800 subjects in the USA. The instrument contained the EQ-5D valuation questionnaire and the items of the SF-12. In addition, the subjects were asked to provide demographic information, complete a depression screening item and to indicate if they had any of seven common chronic conditions. The usable response rate was 23.7%. Patients indicating a health problem on the EQ-5D had significantly lower mean SF-12 component scores (i.e. MCS-12 and PCS-12) for all dimensions. As was expected, the relationships were stronger between the EQ-5D functional dimensions and the PCS-12 and between the MCS-12 and the EQ-5D anxiety/depression dimension. The EQ-5D visual analogue scale (VAS) scores were positively correlated with both component scores; r = 0.55 for PCS-12 and r = 0.41 for MCS-12. The results of this investigation provide support for the validity of both the EQ-5D and the SF-12 as descriptive measures of health status. The measurements by both instruments behaved in patterns that were consistent with recognized sociodemographic differences in health status. The limitations of the dimensional structure of the EQ-5D were somewhat overcome by the use of the VAS, which may also be possible with a constructed index score based on explicit values derived from a general population. The SF-12 appeared to be more sensitive to differences associated with less severe morbidity.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 50 条
  • [1] Comparison of the EQ-5D and SF-12 in an adult US sample
    J. A Johnson
    S. J Coons
    [J]. Quality of Life Research, 1998, 7 : 155 - 166
  • [2] Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample
    Franks, P
    Lubetkin, EI
    Gold, MR
    Tancredi, DJ
    Jia, HM
    [J]. MEDICAL DECISION MAKING, 2004, 24 (03) : 247 - 254
  • [3] Converting the SF-12 into the EQ-5D An Empirical Comparison of Methodologies
    Chuang, Ling-Hsiang
    Kind, Paul
    [J]. PHARMACOECONOMICS, 2009, 27 (06) : 491 - 505
  • [4] VALIDITY OF EQ-5D AND SF-12 AMONG MALAYSIAN
    Shafie, A. A.
    Hassali, M. A.
    Liau, S. Y.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A542 - A542
  • [5] EQ-5D Versus SF-12 in Coronary Patients: Are They Interchangeable?
    De Smedt, Delphine
    Clays, Els
    Annemans, Lieven
    De Bacquer, Dirk
    [J]. VALUE IN HEALTH, 2014, 17 (01) : 84 - 89
  • [6] Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
    Sullivan, Patrick W.
    Ghushchyan, Vahram
    [J]. MEDICAL DECISION MAKING, 2006, 26 (04) : 401 - 409
  • [7] THE PERFORMANCE OF THE GERMAN EQ-5D IN A GENERAL PRACTICE SAMPLE AND ITS COMPARABILITY TO THE SF-12
    Guethlin, Corina
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1545 - 1545
  • [8] Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada
    Johnson, JA
    Pickard, AS
    [J]. MEDICAL CARE, 2000, 38 (01) : 115 - 121
  • [9] Predicting EuroQoL EQ-5D preference scores from the SF-12 health survey in a nationally representative sample
    Lawrence, WF
    Fleishman, JA
    [J]. MEDICAL DECISION MAKING, 2004, 24 (02) : 160 - 169
  • [10] Health-related quality of life in pregnant women living with HIV: a comparison of EQ-5D and SF-12
    Xiaowen Wang
    Guangping Guo
    Ling Zhou
    Jiarui Zheng
    Xiumin Liang
    Zhanqin Li
    Hongzhuan Luo
    Yuyan Yang
    Liyuan Yang
    Ting Tan
    Jun Yu
    Lin Lu
    [J]. Health and Quality of Life Outcomes, 15